137 related articles for article (PubMed ID: 31519569)
1. Metformin Prevents Peritoneal Dissemination
Hirayama T; Nagata Y; Nishida M; Matsuo M; Kobayashi S; Yoneda A; Kanetaka K; Udono H; Eguchi S
Anticancer Res; 2019 Sep; 39(9):4699-4709. PubMed ID: 31519569
[TBL] [Abstract][Full Text] [Related]
2. Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.
Ranjan A; Wright S; Srivastava SK
Oncotarget; 2017 Jul; 8(29):47632-47641. PubMed ID: 28512255
[TBL] [Abstract][Full Text] [Related]
3. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
Front Immunol; 2021; 12():609295. PubMed ID: 33717093
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
Xu P; Yin K; Tang X; Tian J; Zhang Y; Ma J; Xu H; Xu Q; Wang S
Biomed Pharmacother; 2019 Dec; 120():109458. PubMed ID: 31550676
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma.
Siret C; Collignon A; Silvy F; Robert S; Cheyrol T; André P; Rigot V; Iovanna J; van de Pavert S; Lombardo D; Mas E; Martirosyan A
Front Immunol; 2019; 10():3070. PubMed ID: 32038621
[TBL] [Abstract][Full Text] [Related]
6. Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.
Li L; Wang L; Li J; Fan Z; Yang L; Zhang Z; Zhang C; Yue D; Qin G; Zhang T; Li F; Chen X; Ping Y; Wang D; Gao Q; He Q; Huang L; Li H; Huang J; Zhao X; Xue W; Sun Z; Lu J; Yu JJ; Zhao J; Zhang B; Zhang Y
Cancer Res; 2018 Apr; 78(7):1779-1791. PubMed ID: 29374065
[TBL] [Abstract][Full Text] [Related]
7. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
9. Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.
Tang CH; Chang S; Hashimoto A; Chen YJ; Kang CW; Mato AR; Del Valle JR; Gabrilovich DI; Hu CC
Cancer Immunol Res; 2018 Jun; 6(6):696-710. PubMed ID: 29650518
[TBL] [Abstract][Full Text] [Related]
10. Targeting myeloid-derived suppressive cells in the tumor microenvironment to enhance the efficacy of cancer immunotherapy.
Huo S; Liu L; Li Q; Wang J
Discov Med; 2020; 30(161):119-128. PubMed ID: 33593480
[TBL] [Abstract][Full Text] [Related]
11. CD244
Sugita Y; Yamashita K; Fujita M; Saito M; Yamada K; Agawa K; Watanabe A; Fukuoka E; Hasegawa H; Kanaji S; Oshikiri T; Matsuda T; Nakamura T; Suzuki S; Kakeji Y
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907826
[TBL] [Abstract][Full Text] [Related]
12. Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.
Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R
Clin Cancer Res; 2017 Sep; 23(17):5187-5201. PubMed ID: 28698201
[TBL] [Abstract][Full Text] [Related]
13. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib Treatment-elicited Distinct Tumor Microenvironment Dramatically Compensated the Reduction of Myeloid-derived Suppressor Cells.
Fu SY; Wang CC; Chen FH; Yu CF; Hong JH; Chiang CS
In Vivo; 2020; 34(3):1141-1152. PubMed ID: 32354903
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Effects of Metformin on Gastric Cancer
Sekino N; Kano M; Matsumoto Y; Sakata H; Murakami K; Toyozumi T; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Kamata T; Ryuzaki T; Matsubara H
Anticancer Res; 2018 Nov; 38(11):6263-6269. PubMed ID: 30396946
[TBL] [Abstract][Full Text] [Related]
17. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
18. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Metformin's Immunomodulatory Effects on Immune Cells to Combat Breast Cancer.
Petrovic A; Jovanovic I; Stojanovic B; Dimitrijevic Stojanovic M; Stojanovic BS; Jurisevic M; Simovic Markovic B; Jovanovic M; Jovanovic M; Jovanovic M; Gajovic N
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892058
[TBL] [Abstract][Full Text] [Related]
20. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.
Mao Y; Eissler N; Blanc KL; Johnsen JI; Kogner P; Kiessling R
Clin Cancer Res; 2016 Aug; 22(15):3849-59. PubMed ID: 26957560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
